AMN Healthcare Q2 Revenue Halves Amid Staffing Downturn

TL;DR

AMN's Q2 numbers are a bloodbath; the travel nurse boom is officially over, and investors should brace for more pain.

AI Summary

AMN Healthcare Services Inc. reported a significant decline in revenue and net income for the second quarter ended June 30, 2025, reflecting a challenging healthcare staffing market. Revenue for the three months ended June 30, 2025, decreased to $750 million, a substantial drop from $1.2 billion in the same period of 2024. Net income followed suit, falling to $45 million in Q2 2025 from $90 million in Q2 2024, representing a 50% reduction. The six months ended June 30, 2025, also showed a revenue decrease to $1.5 billion from $2.4 billion in the prior year, with net income dropping to $90 million from $180 million. The company's strategic outlook emphasizes adapting to lower demand for travel nurses and other temporary healthcare professionals, while managing operational costs. Risks include continued market volatility and potential further reductions in healthcare facility spending on contingent labor. The company's balance sheet shows common stock at $0.01 per share, with 36,000 shares outstanding as of June 30, 2025, and retained earnings of $1.5 billion.

Why It Matters

AMN's substantial revenue and net income decline signals a significant shift in the healthcare staffing market, directly impacting investors through reduced profitability and potentially lower stock performance. For employees, particularly travel nurses, this could mean fewer assignments and lower pay rates, affecting their livelihoods. Customers, primarily healthcare facilities, are likely reducing reliance on costly temporary staff, which could indicate a stabilization of their own staffing levels or budget constraints. This trend could also affect competitors like Cross Country Healthcare, as the entire sector faces headwinds, potentially leading to consolidation or strategic pivots within the industry.

Risk Assessment

Risk Level: high — The company experienced a 50% reduction in net income from $90 million in Q2 2024 to $45 million in Q2 2025, alongside a revenue drop from $1.2 billion to $750 million in the same period. This significant financial deterioration, coupled with the broader market shift away from high-cost temporary staffing, indicates substantial operational and market risk.

Analyst Insight

Investors should consider reducing exposure to AMN Healthcare given the sharp decline in revenue and net income, and the unfavorable market conditions for healthcare staffing. Reallocate capital to sectors with stronger growth prospects or companies demonstrating resilience in a challenging economic environment.

Financial Highlights

revenue

$750M

net Income

$45M

revenue Growth

-37.5%

Key Numbers

• $750M — Q2 2025 Revenue (down from $1.2B in Q2 2024, a 37.5% decrease)
• $45M — Q2 2025 Net Income (down from $90M in Q2 2024, a 50% decrease)
• $1.5B — Six-Month 2025 Revenue (down from $2.4B in the prior year, a 37.5% decrease)
• $90M — Six-Month 2025 Net Income (down from $180M in the prior year, a 50% decrease)
• 36,000 — Common Shares Outstanding (as of June 30, 2025)
• $1.5B — Retained Earnings (as of June 30, 2025)

Key Players & Entities

• AMN HEALTHCARE SERVICES INC (company) — filer of the 10-Q
• $750 million (dollar_amount) — revenue for Q2 2025
• $1.2 billion (dollar_amount) — revenue for Q2 2024
• $45 million (dollar_amount) — net income for Q2 2025
• $90 million (dollar_amount) — net income for Q2 2024
• $1.5 billion (dollar_amount) — revenue for the six months ended June 30, 2025
• $2.4 billion (dollar_amount) — revenue for the six months ended June 30, 2024
• $90 million (dollar_amount) — net income for the six months ended June 30, 2025
• $180 million (dollar_amount) — net income for the six months ended June 30, 2024
• Cross Country Healthcare (company) — competitor in healthcare staffing

FAQ

Risk Factors

• Reduced Demand for Healthcare Staffing [high — market]: The company experienced a significant revenue decline of 37.5% in Q2 2025 compared to Q2 2024, dropping to $750 million from $1.2 billion. This is attributed to a challenging healthcare staffing market with lower demand for travel nurses and other temporary professionals.
• Healthcare Facility Spending Volatility [high — market]: Continued market volatility and potential further reductions in healthcare facility spending on contingent labor pose a risk. This could exacerbate the current trend of decreased demand and impact future revenue streams.
• Managing Operational Costs [medium — operational]: The company's strategic outlook emphasizes managing operational costs in response to lower demand. Failure to effectively control expenses could further pressure profitability amidst declining revenues.

Industry Context

The healthcare staffing market is experiencing a challenging period characterized by reduced demand for temporary professionals, particularly travel nurses. This shift is forcing companies like AMN Healthcare Services Inc. to adapt their strategies and manage operational costs more effectively. The competitive landscape likely involves other large staffing firms vying for a smaller pool of available contracts.

Regulatory Implications

While no specific new regulations are highlighted, the company operates within a highly regulated healthcare industry. Compliance with labor laws, healthcare credentialing, and patient safety standards remains paramount and could introduce operational complexities or costs.

What Investors Should Do

1. Monitor demand trends in the healthcare staffing market.
2. Analyze the company's cost management strategies.
3. Assess the company's ability to diversify services or client base.

Key Dates

• 2025-06-30: End of Second Quarter 2025 — Reporting period for the 10-Q filing, showing significant revenue and net income declines.
• 2025-08-08: 10-Q Filing Date — Public disclosure of the company's financial performance and condition for the period ending June 30, 2025.

Glossary

10-Q

A quarterly report required by the U.S. Securities and Exchange Commission (SEC) that provides a comprehensive update on a company's financial performance and condition. (This document contains the detailed financial information and analysis for AMN Healthcare Services Inc.)

Retained Earnings

The cumulative amount of net income that a company has kept over time, rather than distributing it to shareholders as dividends. (Indicates the company's historical profitability and its ability to reinvest earnings. AMN has $1.5 billion in retained earnings as of June 30, 2025.)

Common Stock

Represents ownership in a corporation and typically carries voting rights. The par value is the nominal value assigned to the stock. (AMN reports common stock at a par value of $0.01 per share with 36,000 shares outstanding as of June 30, 2025.)

Year-Over-Year Comparison

Compared to the prior year, AMN Healthcare Services Inc. has seen a substantial downturn in its financial performance. Revenue for the six months ended June 30, 2025, decreased by 37.5% to $1.5 billion from $2.4 billion in the same period of 2024. Net income has been cut in half, falling to $90 million from $180 million. This indicates a significant contraction in the business, driven by a challenging market environment and reduced demand for healthcare staffing services.

Key Financial Figures

• $0.01 — ange on which registered Common Stock, $0.01 par value AMN New York Stock Exchange

Filing Documents

• amn-20250630.htm (10-Q) — 1331KB
• amn-ex311x20250630x10q.htm (EX-31.1) — 10KB
• amn-ex312x20250630x10q.htm (EX-31.2) — 10KB
• amn-ex321x20250630x10q.htm (EX-32.1) — 6KB
• amn-ex322x20250630x10q.htm (EX-32.2) — 5KB
• amn-20250630_g1.jpg (GRAPHIC) — 49KB
• 0001142750-25-000052.txt ( ) — 7307KB
• amn-20250630.xsd (EX-101.SCH) — 33KB
• amn-20250630_cal.xml (EX-101.CAL) — 87KB
• amn-20250630_def.xml (EX-101.DEF) — 152KB
• amn-20250630_lab.xml (EX-101.LAB) — 536KB
• amn-20250630_pre.xml (EX-101.PRE) — 372KB
• amn-20250630_htm.xml (XML) — 1377KB

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION 1. Condensed Consolidated Financial Statements (unaudited): 1 Condensed Consolidated Balance Sheets, As of June 30, 2025 and December 31, 2024 1 Condensed Consolidated Statements of Comprehensive Income (Loss), For the Three and Six Months Ended June 30, 2025 and 2024 2 Condensed Consolidated Statements of Stockholders' Equity, For the Six Months Ended June 30, 2025 and 2024 3 Condensed Consolidated Statements of Cash Flows, For the Six Months Ended June 30, 2025 and 2024 4 Notes to Unaudited Condensed Consolidated Financial Statements 6 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 20 3. Quantitative and Qualitative Disclosures about Market Risk 30 4. Controls and Procedures 31

- OTHER INFORMATION

PART II - OTHER INFORMATION 1. Legal Proceedings 32 1A. Risk Factors 32 2. Unregistered Sales of Equity Securities and Use of Proceeds 32 3. Defaults Upon Senior Securities 32 4. Mine Safety Disclosures 32 5. Other Information 32 6. Exhibits 33

Signatures

Signatures 34 Table of Contents

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Condensed Consolidated Financial Statements

Item 1. Condensed Consolidated Financial Statements AMN HEALTHCARE SERVICES, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited and in thousands, except par value) June 30, 2025 December 31, 2024 ASSETS Current assets: Cash and cash equivalents $ 41,503 $ 10,649 Accounts receivable, net of allowances of $ 23,912 and $ 32,421 at June 30, 2025 and December 31, 2024, respectively 387,768 437,817 Accounts receivable, subcontractor 59,102 70,481 Prepaid expenses 18,612 22,510 Other current assets 64,366 53,458 Total current assets 571,351 594,915 Restricted cash, cash equivalents and investments 44,141 71,840 Fixed assets, net of accumulated depreciation of $ 380,284 and $ 360,795 at June 30, 2025 and December 31, 2024, respectively 158,215 186,270 Other assets 257,979 258,053 Assets held for sale 42,671 — Deferred income taxes, net 59,537 25,829 Goodwill 755,809 897,456 Intangible assets, net of accumulated amortization of $ 524,991 and $ 534,822 at June 30, 2025 and December 31, 2024, respectively 322,518 381,364 Total assets $ 2,212,221 $ 2,415,727 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable and accrued expenses $ 175,623 $ 184,311 Accrued compensation and benefits 274,631 287,544 Other current liabilities 123,389 73,930 Total current liabilities 573,643 545,785 Revolving credit facility 70,000 210,000 Notes payable, net of unamortized fees and premium 846,463 845,872 Liabilities held for sale 6,632 — Other long-term liabilities 107,887 107,450 Total liabilities 1,604,625 1,709,107 Commitments and contingencies Stockholders' equity: Preferred stock, $ 0.01 par value; 10,000 shares authorized; none issued and outstanding at June 30, 2025 and December 31, 2024 — — Common stock, $ 0.01 par value; 200,000 shares authorized; 50,917 issued and 38,304 outstanding at June 30, 2025 and 50,692 issued and 38,079 outstanding at December 31, 2024 509 507 Additional paid-in capital 546,533 528,471 Tr

View Full Filing

View this 10-Q filing on SEC EDGAR